Category: Johnson & Johnson
A federal jury in Texas clears Johnson & Johnson's DePuy Pinnacle hip implant in the 1st bellwether product liability trial over the metal-on-metal device.
A federal jury in Texas reportedly clears Johnson & Johnson's DePuy Pinnacle hip implant in the 1st bellwether product liability trial over the metal-on-metal device.
UPDATED Oct. 23, 2014, with comment from DePuy.
A jury begins deliberations in the 1st trial over DePuy Orthopaedics' Pinnacle metal-on-metal hip implant.
Here's a look at some of the top regulatory stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit
, Becton Dickinson & Co.
, DePuy Synthes
, GenCell Biosystems
, Johnson & Johnson
, Kimberly-Clark Worldwide Inc.
, MAKO Surgical Corp.
, Stryker Corp.
, Valeant Pharmaceuticals
, 3M Corp.
, Allergan Inc.
A federal judge bars sales of Johnson & Johnson unit Ethicon Endo-Surgery's Harmonic Ace +7 surgical shears in a patent infringement lawsuit brought by Covidien.
More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson continues to take hefty charges on integrating the orthopedics company into its DePuy franchise.
Johnson & Johnson's 2nd-quarter sales top forecasts, prompting the medical product giant to raise its full-year earnings guidance.